Prescription Drug Search Results: Actoplus Met

FDA Approves ACTOplus met XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
First and only oral antidiabetic fixed-dose combination medication approved with the extended-release form of metformin DEERFIELD, Ill. and OSAKA, Japan, May 13 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary,... (Source: Drugs.com - New Drug Approvals)

Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving Actos (pioglitazone HCI), ACTOplus met (pioglitazone HCl and metformin HCl) and duetact(R) (pioglitazone HCl and glimepiride)
DEERFIELD, Ill. and OSAKA, Japan, Dec. 21, 2010 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) today announced that Takeda and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc. (TPNA), have completed... (Source: Drugs.com - Pharma News)